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ABSTRACT
Peroxisome proliferator activated receptor α (PPARα) is a ligand-dependent transcription factor that regulates the expression of
genes involved in lipid metabolism and transport. Activators of PPARα may be potential hypolipidemic agents, like the fibrate-type
drugs. This study was therefore aimed at identifying potential hypolipidemic functional foods by screening activators of PPARα
from food materials. CHO-K1 cells were stably transfected with vectors (pBKCMV) carrying cDNAs of a (UAS)4 -tk-alkaline phosphatase reporter and a chimeric receptor Gal4-PPARα LBD successively. Clones of cells responsive to Wy-14643, a known PPARα
activator were selected, characterized and used for testing the PPARα activating potency of fractions extracted from food materials.
Food materials were extracted with ethyl acetate and the extract (EAE) was cold-saponified and tested for the PPARα activating ability using the selected stable transfected clone of cells. 10 µM Wy-14643 (WY) was used as the positive control. Among
food materials tested, EAE of bitter gourd showed the highest activity that exceeded Wy-14643, although the activity significantly
decreased after saponification. The non-saponifiable fraction of onion EAE had a high maximal fold of activation equivalent to
Wy-14643, while that of peanut, lychee, ricinus seed and longan showed moderate activity. The saponifiable fraction of ricinus seed,
sesame and peanut also showed moderate activity. Further investigation is needed to explore the health benefit of the PPARα activating food extracts found in this study.
Key words: PPARα, stable transfection, bitter gourd

INTRODUCTION
Peroxisome proliferator-activated receptors (PPARs)
are lipid-activated transcription factors that control
energy homeostasis through genomic action (1). As other
members of nuclear steroid hormone receptor superfamily, PPARs have common modulatory structures including
a DNA-binding domain and a ligand-binding domain (2,3).
Upon activation by ligand binding, PPAR heterodimerizes with retinoid X receptor (RXR) and promotes the
transcription of its target genes through binding to a
peroxisome proliferator responsive element (PPRE)(1,2).
Three subtypes of PPAR exist, namely PPARα (NR1C1),
PPARβ/δ (NR1C2) and PPARγ (NR1C3), which display
tissue-selective expression pattern and distinct biological functions. PPARα is predominantly expressed in
liver, heart, kidney and skeletal muscle where it controls
the fatty acid catabolism. PPARα regulates the expression of genes encoding proteins that are involved in lipid
* Author for correspondence. Tel: +886-4-23323456 ext. 1859;
E-mail: cychao@asia.edu.tw

metabolism, fatty acid oxidation, and glucose homeostasis, thereby improving markers for atherosclerosis
and insulin resistance. In addition, PPARα exerts antiinflammatory effects both in the vascular wall and the
liver (4). PPARγ is highly expressed in brown and white
adipose tissue where it triggers cellular differentiation,
promotes lipid storage and modulates the action of insulin. PPARβ/δ is ubiquitously expressed and controls
brain lipid metabolism and fatty acid-induced adipogenesis and preadipocyte proliferation(1,2). Recent reports
further demonstrated a role of PPAR in regulating
glucose homeostasis, cellular differentiation and apoptosis, cancer development as well as in the control of the
inflammatory response (4,5,6).
Being the ligand / activator of PPARα, the fibratetype hypolipidemic drugs can induce the expression of
genes that participate in lipid catabolism such as fatty
acid uptake and binding, fatty acid oxidation in microsomes, peroxisomes and mitochondria and lipoprotein
assembly and transport (3). These are PPARα target genes
since PPRE has been identified in the promotor region
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of these genes. Using the PPARα deficient mice model,
the hypolipidemic action of fibrates has been found to be
mediated by this receptor (7). The results indicated that
PPARα ligand / activator may lower liver and/or blood
lipids by up-regulating PPARα target genes which in
turns, enhance the oxidation of fatty acids (3). Likewise,
thiazolidinediones are PPARγ ligands and the antidiabetic effects exerted by this type of drugs is believed to be
mediated by PPARγ(8,9). Substantial attempts have been
made currently to develop new therapeutic agents for
hyperlipidemia, insulin resistance, atherosclerosis, etc.
by screening agonist / antagonist of PPARs (1,3).
In addition to common fatty acids, some compounds
of diet/food origins, such as conjugated linoleic acids,(10)
have been found to be PPAR activators. The hypolipidemic effect of fish oil(11) has been attributed, at least in
part, to the activation of PPARα. We have shown that
hydrolyzed oxidized frying oil can activate PPARα and
up-regulate some PPARα target genes in rats (12). It is thus
desirable to identify more PPARα or PPARγ activators
from food materials from which hypolipidemic or antidiabetic functional foods may potentially be developed.
The purpose of this study is to screen PPARα activators from food materials using a clone of CHO-K1
cells stably transfected with vectors (pBKCMV) carrying cDNAs of a (UAS) 4 -tk-alkaline phosphatase (ALP)
reporter and a chimeric receptor Gal4-PPARα ligand
binding domain(12,13,14). As PPAR activators tend to
be hydrophobic, tested food materials were extracted
with ethyl acetate and the PPARα activating ability was
compared to Wy-14643, a reference PPARα ligand.

MATERIALS AND METHODS
I. Expression and Reporter Plasmids
The construct of chimeric receptor was pBK-CMVGal4-rPPARα-ligand binding domain; the reporter gene
was pBK-CMV-(UAS) 4 -tk-ALP; antibiotic genes were
pSV2-Neomycin and pKSV-Hygromycin. These were
gifts from Dr. Gustaffson, Department of Medical Nutrition, Karolinska Institute. The correct in-frame fusions
were confirmed by sequencing.
II. Food Materials for Testing
Tested food materials were chosen from vegetables,
fruits, nuts, traditional Chinese herb and microbial products. Fresh vegetables including bitter gourd (Momordica
charantia L.), onion, celery, sweet potato leaves and rice
seedlings and fruits including lychee (litchi, leechee or
lichi, litchi sinesis Sonn) and longan (Nephelium longana Camb or Euphoria longana Lam) were purchased
from local markets. Freshly roasted peanut and sesame
were from a manufacturer (Ma Yu San food processing,
Kaohsiung, Taiwan). Dried traditional Chinese herb

including ricinus seed, lotus seed plumule (Nelumbo
nucifera Gaertn) and hawthorn (Crataegi Fructus) were
purchased from a local Chinese traditional medicine
store. Two microbial products, Monascus anka (dried
powder of Chinese red yeast rice) and Ganoderma tsugae
were from Shuang Hor Enterprise Company, Tainan,
Taiwan. Dried fruiting body of G. tsugae from a cultivation farm and provided by Dr. Hseu.
III. Cell Culture and Stable Transfection
The procedures for the establishment of cell lines
stably transfected with Gal4-rPPARα LBD chimeric
receptor and (UAS) 4 - tk -ALP reporter has been described
previously(12,13). Briefly, CHO-K1 cells (American Type
Culture Collection, Rockville, MD) were grown at 37°C
in the presence of 5% CO2 in Ham’s F-12 medium supplemented with 10% fetal bovine serum (FBS; Gibco BRL,
Rockville, MD). Using lipofectamineTM 2000 (Gibco
BRL) according to the manufacturer’s instructions, cells
were first transfected with the reporter construct and
pSV2-Neo. Transfected cells were selected in the presence of 0.8 mg/mL medium of G418 (neomycin). The
colonies grown were pooled to form a reporter clone
mix and further transfected with the chimeric receptor
construct pBK-CMV-Gal4-rPPARα and pKSV-Hygro, and
then selected with 0.8 mg/mL medium of hygromycin.
About 150 clones were picked, expanded and tested for
their responsiveness to 10 µM Wy-14643 (Cayman Chemicals, Ann Arbor, MI), a known activator of rPPARα.
Among the 10 responsive clones, clone 77 showed the
maximal fold induction of the reporter gene activity, and
was used for the following experiments. The expression
of rPPARα-LBD in cells of the clone 77 was confirmed by
reverse transcription-polymerase chain reaction.
IV. Activation Experiments and ALP Reporter Gene Assay
The procedure has been described previously(12,14).
Briefly, stably transfected cells were seeded in 96-well
plates and incubated with medium containing Wy-14643
or tested food extracts for 48 h. Basal levels of expression
of reporter activity were obtained with medium containing vehicles [dimethyl sulfoxide (DMSO) or ethanol]
at a concentration equivalent to those used in the highest concentrations of activators. Culture supernatants
were collected and assayed for ALP activity using CDPStar ® (Tropix, Applied Biosystems, Foster City, CA) as a
substrate. Chemiluminescence was measured in a luminometer (Wallac 1420 Victor2 multiple label counter;
Perkin Elmer, Turku, Finland). The toxicity of the treatment on cells was checked by the 3-(4,5-dimethylthiazol2-yl) -2,5-diphenyltetrazolium bromide (MTT) (Sigma,
St. Louis, MO) assay. Data are expressed as means of
triplicates from one experiment and are representative of
at least three experiments. Fold of activation was calculated by taking the ALP activity of the vehicle as 1.
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V. Extraction of Food Materials with Organic Solvent
The extraction of tested fresh vegetables, fruits, roasted peanut and lotus seed plumule were as described(15,16).
Briefly, samples were cut into small pieces and homogenized in a Waring blender with minimal amount of doubledistilled water, and homogenates were filtered through
several layers of gauze. The residues were collected and
freeze-dried. The dried residues were grounded and
extracted with ethyl acetate (1:30, w/v) by stirring overnight at room temperature, followed by filtration. Dried
ricinus seed, hawthorn and Monascus anka were ground
and directly extracted with ethyl acetate (1:30, w/v) in the
same manner. Ganoderma tusgae was ground and extracted with 95% ethanol (1:30, w/v). Sesame was ground and
extracted with (1:30, w/v) a mixture of ethyl acetate and
methanol (1:1, v/v) in the same manner. Filtrates were
evaporated in a rotary evaporator (Buchi, Germany) to
eliminate the solvent. The ethyl acetate extracts (EAEs)
were weighed and stored at –20°C. The extraction yield (g
/ 100 g of the dried residue) was shown in Table 1.
VI. Hydrolysis of Food Extracts by Cold Saponification
The EAEs were further hydrolyzed by cold saponification. After an overnight stirring with 10 volume of 3.6
M KOH in methanol at room temperature, the saponifi-

able fractions were extracted with water, acidified with
5 N H 2SO 4 and extracted with n-hexane. The nonsaponifible fractions were extracted with ethyl acetate.
The saponifiable (S) and nonsaponifiable (NS) fractions
were weighed after removing solvent in a rotary vacuum
evaporator. Stock solutions were prepared by dissolving EAE, S or NS in a minimal amount of absolute ethanol and stored at –20°C. The result of the saponification
process was examined by thin layer chromatography
(TLC) as described below and the disappearance of the
triglyceride spot was confirmed. The EAE, S and NS
were resolved on a normal phase TLC (Silica gel 60 F254 ,
Merck, Darmstadt, Germany) developed using n-hexane/
ethyl acetate/ acetic acid at 80: 20: 2 (v/v/v) as the mobile
phase and visualized with iodine vapor. The developed
spots were compared with standard compounds including
oleic acid, linoleic acid, linolenic acid and triolein.
VII. Statistical Analysis
Data reported are expressed as the mean ± standard
deviation of triplicate wells, and are representative of
at least three separate experiments with similar results.
The significance of difference between each treatment
was analyzed by one-way ANOVA using SASR (SAS 8.1,
Cary, N.C., USA) software.

RESULTS
I. Dose Response Curve for Clone 77 with Wy-14643
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Figure 1. Dose response curve of Wy-14643 in CHO-K1 cells stably
expressing the Gal4-rPPARα receptor chimera and the (UAS)4 -alkaline phosphatase (ALP) reporter. CHO-K1 cells were successively
transfected with the reporter and receptor construct. Clones showing
low background and maximum fold activation of the reporter by 10
µM Wy-14643 were expanded and treated with various concentrations of Wy-14643 for 48 h. The cultural supernatant was analyzed
for alkaline phosphatase reporter activity. The fold of activation was
calculated by taking the ALP activity of the vehicle (ethanol) as 1.
The data were mean ± SD of triplicates from one experiment and are
representative of at least three experiments.

To establish a cell clone (CHO-K1) stably expressing
the chimeric receptor in which the PPARα ligand-binding domain was fused to a DNA-binding domain of the
yeast transcription factor GAL4 and an ALP reporter
gene fused to (UAS) 4, about 150 transfected cell clones
that grew in the presence of 0.8 mg/mL hygromycin were
picked, expanded and tested for the responsiveness to
Wy-14643. Ten clones were found to be responsive and
further expanded. The expression of the ALP reporter
gene of one of the responsive clone, clone 77, in response
to Wy-14643 in a dose-dependent manner is shown in
Figure 1. The cell lines obtained were used for testing
the PPARα activating potential of various food extracts
in the following experiments. Among various batches
of experiments, the fold activation of 10 µM Wy-14643
ranged from 2 to 4.
II. The PPARα Activation Potential of Tested Food Extracts
The ethyl acetate extracts (EAE), as well as their
saponifiable (S) or non-saponifiable (NS) fractions of
tested food materials were examined for the PPARα activation potential using cells of the clone 77. The results
are shown in Table 1. Among the EAEs of food materials tested, bitter gourd showed a high activity with the
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Table 1. Activation of PPARα by various food extracts
Extract of
food materials

extraction
yield

concentration at maximum
fold activation

EAE4

(g / 100 g)

(µg / mL)

Bitter gourd

1.86

100

7.22*1 (2.66)2

375*3

Lotus seed plumule

17.25

500

1.36 (2.02)

35

Ricinus seed

49.60

30

1.53 (2.59)

33

Sesame (EME)

31.80

500

1.39 (2.50)

26

Onion

1.50

90

1.36 (2.50)

24

Longan

1.53

100

1.26 (2.29)

20

Peanut

31.40

100

1.23 (2.65)

14

Lychee

2.43

100

1.14 (2.78)

8

Others 5

maximum fold
of activation

% relative fold activation
to 10 µM Wy-14643
(%)

< 1 (2.02~3.3)
S4

(g / 100 g)

(µg / mL)

Ricinus seed

27.6

70

1.70 (2.50)

47

Sesame (EME)

18.1

200

1.80 (2.70)

47

Peanut

17.5

100

1.42 (2.35)

31

Onion

0.12

1

1.42 (2.73)

24

Lotus seed plumule

2.8

100

1.37 (2.71)

22

Bitter gourd

0.24

90

1.26 (2.72)

15

Longan

0.05

10

1.08 (2.56)

5

Lychee

0.16

1

1.01 (2.61)

<1

Others 5

(%)

< 1 (2.02~3.3)
NS4

(g / 100 g)

(µg / mL)

Onion

0.69

90

3.10* (3.30)

91

Peanut

6.09

50

1.65 (2.35)

48

Lychee

1.14

50

1.76 (2.61)

47

Ricinus seed

7.35

50

1.70 (2.65)

42

Longan

0.74

200

1.44 (2.24)

36

Bitter gourd

1.44

150

1.57 (2.72)

33

Sesame (EME)

7.18

100

1.41 (2.78)

23

Lotus seed plumule

7.29

100

1.17 (2.09)

16

Others5

(%)

< 1 (2.02~3.3)

1. The fold of activation was calculated by taking the ALP activity of the vehicle (ethanol) as 1. Data are means of triplicates from one
experiment and are representative of at least three experiments. (*) P < 0.05, significantly different from Wy-14643.
2. Numbers in parenthesis are the fold of activation of 10 µM Wy-14643 in the same batch of experiment.
3. (Maximum fold activation of food sample–vehicle) / (fold activation of 10 µM Wy-14643 in the same batch of experiment–vehicle) x 100.
(*) P < 0.05, significantly different from Wy-14643.
4. EAE : ethyl acetate extract; S : saponifiable fraction of the EAE; NS : nonsaponifiable fraction of the EAE; EME : ethyl acetate and
methanol (1:1) extract.
5. Others including rice seedlings, sweet potato leaves, celery, hawthorn, Monascus anka and Ganoderma tsuga (ethanol extract).

66
Journal of Food and Drug Analysis, Vol. 16, No. 4, 2008

maximum fold of activation more than three hundred
percents of Wy-14643. However, the activity significantly decreased after saponification. The maximal fold of
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Figure 2. The transactivation of Gal4-rPPARα by bitter gourd ethyl
acetate extract (–  –), its saponifiable (–  –) and nonsaponifiable
(–  –) fractions. The data were expressed as mean ± SD of triplicate
wells in a representitive experiment. Data shown are representitive of at least triplicate separate experiments with similar results.
Wy-14643 (10 µM) was included in each experiment as a positive
control. The EC50 of the EAE was 70 µg/mL. *P < 0.05 compared to
vehicle control. # P < 0.01 compared to vehicle control.
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activation of the remaining tested food EAEs were relatively low but increased after saponification except for
lotus seed plumule. The non-saponifiable fraction of the
onion EAE had a high maximal fold of activation equivalent to Wy-14643, while that of peanut, lychee, ricinus
seed and longan had moderate activity (36-48% that of
Wy-14643). The saponifiable fraction of ricinus seed and
sesame also showed moderate activity (47% that of Wy14643). On the other hand, while EAE, S or NS of lotus
seed plumule showed low activity, those of celery, sweet
potato leaves, rice seedlings, hawthorn, Monascus anka
and ethanol extract of Ganoderma tsuga did not activate
PPARα at all.
The dose-dependent activation of bitter gourd EAE
is shown in Figure 2. The EC50 was 70 µg/mL. Interestingly, the high activation pontency dramatically decreased
after the bitter gourd EAE was saponified (Figure 2). In
contrast, the EAE of onion did not show a high fold of
activation, but after hydrolysis, the NS increased the ALP
activity to an extent comparable to 10 µM of Wy-14643 in
a dose-dependent manner (Figure 3). The EC50 was 30 µg/
mL. The NS of ricinus seed EAE and S of sesame EME
also activated PPARα to a significant extent, with EC50
values of 10 µg/mL and 30 µg/mL, respectively (Figure 4
and Figure 5). The fold activation of the S of ricinus seed
EAE was comparable to that of ricinoleic acid, and the fold
activation of the S of sesame EME were in the range of
that of common fatty acids such as oleic acid and linoleic
acid. All these testing were carried out in concentration
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Figure 3. The transactivation of Gal4-rPPARα by the nonsaponifiable fraction of onion ethyl acetate extract. The data were expressed
as mean ± SD of triplicate wells in a representitive experiment. Data
shown are representitive of at least triplicate separate experiments
with similar results. Wy-14643 (10 µM) was included in each experiment as a positive control. The EC50 of the nonsaponifiable fraction
of the onion EAE was 30 µg/mL. *P < 0.05 compared to vehicle
control.
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Figure 4. The transactivation of Gal4-rPPARα by the nonsaponifible fraction of ricinus seed ethyl acetate extract. The data were
expressed as mean ± SD of triplicate wells in a representitive experiment. Data shown are representitive of at least triplicate separate
experiments with similar results. Wy-14643 (10 µM) was included
in each experiment as a positive control. The EC50 of the nonsaponifible fraction of the ricinus seed EAE was 10 µg/mL. *P < 0.05
compared to vehicle control.
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Figure 5. The transactivation of Gal4-rPPARα by the saponifible
fraction of sesame ethyl acetate and methanol (1 : 1) extract (EME).
The data were expressed as mean ± SD of triplicate wells in a representitive experiment. Data shown are representitive of at least triplicate separate experiments with similar results. Wy-14643 (10 µM)
was included in each experiment as a positive control. The EC50 of
the saponifible fraction of the sesame EME was 30 µg/mL. *P < 0.05
compared to vehicle control.

ranges that did not result in significant cytotoxicity, as
confirmed by the MTT assay.

DISCUSSION
Ligand binding of PPARs can induce the expression
of an array of genes which in turns changes the metabolism of lipids and/or the utilization of glucose. A number
of therapeutic agents, namely fibrate hypolipidemic drugs
and thiazolidinedione antidiabetic drugs, are ligands of
PPARs and the pharmocological effects were shown to
be mediated by these nuclear receptors(3,8,9). The transactivation assay are used to test the functional potency of
a compound to activate PPAR. The assay measures the
expression of a reporter gene which is driven by a promotor responsive to the specific binding of the transcription factor and in this case it is the PPAR. As PPARs are
ligand dependent transcription factors, molecules bind
to PPARs would activate the expression of the reporter
gene. To avoid complicating the interpretation of results
by endogenous receptor activation, a chimeric receptor in
which the PPARα ligand binding domain fused to yeast
transcription factor GAL4 DNA binding domain and a
reporter construct containing 4 copies of the GAL4 DNA
binding site UAS driving expression of secreted placental
ALP were used in this study. The approach is similar to
that used for screening compounds in the pharmaceutical
research and development(17). Compared to the transient

transfection approach, it is more convenient to use clone
of cells stably expressing the transfected receptor and
reporter for compound screening. However, it usually
takes longer time to obtain such a clone and very often the
clone may suffer from the instability and loss of sensitivity due to passages of cells. In this study, this can be seen
from the variation in the fold of activation of the positive
control, Wy-14643.
Common fatty acids are low affinity ligands of
PPARs(18-20). The fold of activation on PPARs by common
fatty acids varied with the receptor and reporter constructs,
cell types for transfection as well as species of PPARs
originated from (mouse, rat, human or Xenopus)(18,21,22).
In this study, the fold of activation on PPARs by common
fatty acids(18,23) relative to that of Wy-14643 is within the
range of reported data.
The ethyl acetate extract of food materials was chosen
for this study since the conformation of ligand binding
structure of PPARα is apt to hydrophobic molecules. In
an attempt to include the more polar lignan compounds
of sesame in the tested extract, a methanol/ethyl acetate
mixture was further used to extract sesame. Sesamin, a
sesame lignan, dose-dependently increased the fatty acid
oxidation, activities and gene expression of hepatic fatty
acid oxidation enzymes and decreased serum triglyceride
in rats(24). Authors speculated the effect may be mediated
by the PPARα signaling pathway. Surprisingly, sesamin
and sesamol did not activate PPARα in the present study,
although the saponifiable fraction of sesame extract activated PPARα to a level comparable to commom fatty acids. As
there is not a carboxylic acid functional group in the sesamin molecule, the convincing in vivo data obtained in the
rat study may be interpreted as sesamin metabolite(s) and
not sesamin per se, may activate PPARα. CHO-K1 cells
used in this study might not be able to metabolize sesamin
into this active metabolite. If this is the case, the transfection experiment should be carried out in other cell types,
such as liver cells. Alternately, sesamin may enhance the
production of an endogenous PPARα activator in vivo.
Bitter gourd is a common oriental vegetable with
a number of reported health benefits. Most noteworthy
is the hypoglycemic potential demonstrated in normal
and diabetic rats as well as in human subjects with type
II diabetes mellitus(25-27). A diet containing 0.5 or 1%
freeze-dried bitter gourd powder significantly reduced
liver triglyceride and cholesterol concentration(28). In
the present study, the maximum fold activation of bitter
gourd EAE was remarkably high which was more than
three hundred percents relative to the fold of activation of
Wy-14643. The significant hypolipidemic effect in vivo
at a level of as low as 0.5% in the diet seems to coincide
with the remarkably high PPARα activation observed in
this study. Interestingly, the PPARα activation ability was
diminished after the saponification of bitter gourd EAE.
An anti-inflammatory potential of bitter gourd is implicated by the demonstration that extracts of bitter gourd dosedependently inhibited the LPS-induced PGE2 production
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in a macrophage cell line RAW264.7(15).
Our data showed that the nonsaponifiable fraction of
the onion EAE has a significant PPARα activation ability
with the maximum fold of activation comparable to that of
Wy-14643. As compounds with carboxylic acid functional
groups will mainly be separated into the saponifiable fraction, constituents of the nonsaponifiable fraction theoretically do not possess any carboxylic acid functional group.
It is likely that compound(s) in the nonsaponifiable fraction of onion EAE may not be the ultimate PPARα ligand.
Noticeably, hypolipidemic and hypoglycemic effects exerted by onion has also been demonstrated in diabetic rats(29).
It would be of interest to further test the PPARγ activation
potential and the active component(s) in bitter gourd and
onion. In addition, the in vivo regulation of the expression
of PPAR target genes by the administration of bitter gourd
extract or onion also worth further investigation.
In conclusion, using a clone of CHO-K1 cells stably
expressing a (UAS) 4 -tk-ALP reporter and a chimeric
receptor Gal4-PPARα LBD, extract/fractions of food
materials including: bitter gourd (375% of WY), onion
(91% of WY), peanut (48% of WY), ricinus seed (47% of
WY), sesame (47% of WY), lychee (47% of WY), longan
(36% of WY) and lotus seed plumule (35% of WY)
demonstrated significant activation on PPARα, whereas
extract/fractions of celery, sweet potato leaves, rice seedlings, hawthorn, Monascus anka and Ganoderma tsuga
did not activate PPARα to a significant extent.
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